Blog / AI in Pharma
AI Medical Information for Doctors

How AI Is Changing How Doctors Access Medical Information

Doctors leave half their clinical questions unanswered. See how AI is closing that gap, where it still fails, and how WaaPharma delivers approved answers to HCPs.

Doctor using an AI-powered medical information platform
In brief: Doctors raise about one clinical question for every two patients and leave roughly half of them unpursued, mostly for lack of time (JAMA Internal Medicine). AI is closing that gap fast: 81% of US physicians now use AI at work (AMA, 2026). But general AI models still answer confidently when they shouldn't (Nature Communications, 2025). For pharma, the question is whose approved content answers the doctor.

The Question That Never Gets Asked

It is 6:40 pm in a busy outpatient clinic. A physician is about to add a second agent for a patient with diabetes and reduced kidney function, and she wants to confirm the dose adjustment. The product monograph is a 40-page PDF somewhere in her inbox. The rep visited three weeks ago. Nine patients are still waiting.

So she goes with memory and moves on.

This is not a rare failure. It is the normal pattern, and researchers have measured it.

The "Half-Unanswered" Problem, in Numbers

In a systematic review in JAMA Internal Medicine, Del Fiol and colleagues pooled 72 studies of how clinicians handle questions during patient care:

MeasureFinding
Questions raised0.57 per patient seen
Questions pursued51%
Answers found, when pursued78%

The authors note that this pattern had held for decades, even though online evidence resources were widely available. The problem was never whether answers existed. It was the effort needed to reach them at the moment of care.

From Bookshelf to Answer Engine

How doctors find information has changed in four clear stages:

EraHow doctors got answersThe limit
BookshelfTextbooks, formularies, journalsSlow and quickly out of date
PDF and repMonographs, reprints, rep visitsApproved, but hard to search and easy to ignore
Search boxOnline references, search enginesStill too slow for a 10-minute consult
Answer engineConversational AIFast, but only as reliable as its source

The fourth era is the first one where getting an answer takes about as much effort as asking the question.

What Doctors Are Doing With AI Today

Global Adoption

The AMA's 2026 Physician Survey on Augmented Intelligence, based on responses from about 1,700 physicians, found that:

Purpose-built clinical AI tools are spreading fastest. NBC News reported in May 2026 that one AI medical search tool reached roughly 65% of US doctors in a single month, according to company figures.

In WhatsApp-First Markets

In South Asia, MENA and Southeast Asia, the same behaviour runs through a different channel: the messaging app already on every doctor's phone.

In a national survey of 718 physicians in Pakistan, WhatsApp was the app used most often each week for medical purposes. It was also the most common digital channel pharma companies used to reach those doctors, ahead of websites, apps and e-detailing. A 2026 study of healthcare workers at three tertiary hospitals in Peshawar again found WhatsApp to be the most used platform.

Doctors in these markets are ready for AI answers. They want them in the channel they already use.

Where AI Still Gets Medicine Wrong

Speed is not the same as safety, and the evidence shows it.

A 2023 JAMA Network Open study had 33 specialists grade a general chatbot's answers to 284 medical questions. Accuracy was high on average, but the authors reported important limitations.

Newer research highlights a deeper issue. A 2025 study in Nature Communications tested twelve large language models on medical questions. All of them showed significant metacognitive deficiencies: they failed to recognise the limits of their knowledge and gave confident answers even when no correct option was available.

For a doctor checking a dose, a confident wrong answer is worse than no answer. For a pharma company, open-web AI creates three risks:

Risk 1 – Label Mismatch

The answer may reflect another country's approval, an older label or a withdrawn indication.

Risk 2 – Off-Label Drift

A general model has no concept of what the company is permitted to say.

Risk 3 – Lost Signal

The doctor's question, one of the most valuable data points a brand can get, disappears into a third-party tool.

Governed AI – The Model That Fits Pharma

The fix is not to keep doctors away from AI. It is to give them AI that follows the same rules as every other company communication.

Industry codes already set that bar. The IFPMA Code of Practice, which member companies follow worldwide, requires promotional information to be accurate, not misleading and consistent with approved product information, and it restricts off-label promotion. In the US, the FDA's January 2025 final guidance on scientific information about unapproved uses follows the same logic, although it is not yet in effect pending federal paperwork review. National regulators add their own rules on top.

TraitOpen-web AIGoverned pharma AI
Source of answersWhatever the model learnedOnly the company's approved content
Off-label questionsUnpredictableBlocked, or escalated to Medical Affairs
Who can askAnyoneInvited healthcare professionals
What the company learnsNothingEvery question, by region and product

How WaaPharma Brings Approved Clinical AI to Doctors

WaaPharma was built for this shift. We give pharma brands approved, AI-powered clinical answers from trusted pharma content, delivered inside the app doctors already open dozens of times a day: WhatsApp.

How It Works

  1. A rep sends the doctor a personalised WhatsApp invite with a "Launch WaaPharma" button.

Because WaaPharma runs on Meta WhatsApp Flows, there is no app to download and no login to remember.

Back to the physician at 6:40 pm. With WaaPharma, her dose question takes one message, and the answer she gets is the approved one.

Results From Live Deployments

Frequently Asked Questions

How is AI changing the way doctors access medical information?

It replaces searching through documents with asking direct questions. The AMA reports that 81% of US physicians use AI at work, and research and guideline summaries are the top use.

How often do doctors have unanswered clinical questions?

A JAMA Internal Medicine systematic review found that clinicians raise about 0.57 questions per patient and pursue only about half of them.

Is general AI reliable enough for medical questions?

Not on its own. A 2025 Nature Communications study found that all twelve models tested gave confident answers even when they lacked the correct information. AI restricted to approved sources is safer for clinical and pharma use.

Do doctors in Pakistan use WhatsApp for medical purposes?

Yes. In a national survey of 718 Pakistani physicians, WhatsApp was the most frequently used app each week for medical purposes.

What is WaaPharma?

WaaPharma is a WhatsApp-based clinical AI platform that lets pharma companies answer HCP questions 24/7 from approved content, with real-time analytics on every interaction.

See Approved Clinical AI in Action

Your doctors are already asking AI about your medicines. Make sure the answer is yours. Book a 30-minute WaaPharma demo to see approved medical information delivered to HCPs inside WhatsApp, live in 48 hours.

Book a Demo